Anisindione
General information:
| Withdrawn ID: | 211 |
|---|---|
| Canonical SMILES: | |
| Standard InChI: | |
| Standard InChIKey: | |
| ATC class(es): | B |
| Molecular Formula: | C16H12O3 |
| Molweight: | 252.265 |
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
|---|---|
| First approved: | 1957 |
Filtered ChEMBL targets:
| Target UniProtKB ID | Activity in nm | Target Name | Target gene |
|---|---|---|---|
| O15118 | 5623.4 | NPC intracellular cholesterol transporter 1 | NPC1_HUMAN |
| P04637 | 10000 | Cellular tumor antigen p53 | P53_HUMAN |
| P15428 | 4466.8 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | PGDH_HUMAN |
| P51151 | 4466.8 | Ras-related protein Rab-9A | RAB9A_HUMAN |
| Q16637 | 3981.1 | Survival motor neuron protein | SMN_HUMAN |
Toxicity information:
| Toxicity class: | 4 |
|---|---|
| Toxicity type: | N/A |
| LD50: | 800 mg/kg |
External links:
| ChEBML: | CHEMBL712 |
|---|---|
| DrugBank: | DB01125 |